Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Minute Insight: Thermo Fisher Scientific Wins FDA Clearance For Preeclampsia Blood Test

Executive Summary

The FDA cleared Thermo Fisher’s in vitro diagnostic for preeclampsia, the leading cause of pregnancy morbidity and mortality, based on results from the PRAECIS study.

You may also be interested in...



Mirvie Granted Breakthrough Device Designation For Test To Identify Risk Of Preeclampsia

Mirvie’s RNA platform can identify 75% of women who develop preeclampsia months before symptoms occur.

Akili Introduces Adult Version Of Video Game Therapy To Lessen ADHD Symptoms

Video game therapy developer Akili Interactive launched a mobile video game therapy to reduce ADHD symptoms in adults. The company plans to seek FDA clearance.

Novo Nordisk In Negotiations To Acquire Medical Device Maker Biocorp For About $165M (€154M)

After a nearly two-year collaboration, Novo Nordisk said it has begun talks to buy a controlling stake in French medical device company Biocorp.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147942

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel